Loperamide HCl - CAS 34552-83-5
Catalog number:
34552-83-5
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C29H33ClN2O2.HCl
Molecular Weight:
513.5
COA:
Inquire
Targets:
Opioid Receptor
Description:
Loperamide HCl is an opioid-receptor agonist with an ED50 of 0.15 mg/kg.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
Synonyms:
ADL 2-1294
MSDS:
Inquire
1.Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome.
Lacy BE1. Int J Gen Med. 2016 Feb 11;9:7-17. doi: 10.2147/IJGM.S93698. eCollection 2016.
Irritable bowel syndrome (IBS) is one of the most common gastrointestinal disorders worldwide. The economic impact of IBS on the health care system is substantial, as is the personal impact on patients. Patients with diarrhea-predominant IBS (IBS-D) comprise a substantial proportion of the overall IBS population. Primary care providers are often the first point of contact for patients with IBS-D and can accurately diagnose IBS after a careful history and examination without extensive diagnostic tests. Several pharmacologic treatments (eg, loperamide, alosetron, and antidepressants) and non-pharmacologic treatments (eg, dietary modification and probiotics) are available for IBS-D, but restrictions on use (eg, alosetron) or the lack of controlled trial data showing reductions in both global and individual IBS-D symptoms (eg, bloating, pain and stool frequency) emphasize the need for alternative treatment options. Two newer medications (eluxadoline and rifaximin) were approved in May 2015 for the treatment of IBS-D, and represent new treatment options for this common gastrointestinal condition.
2.Not your regular high: cardiac dysrhythmias caused by loperamide.
Wightman RS1, Hoffman RS1, Howland MA1,2, Rice B3, Biary R1, Lugassy D1. Clin Toxicol (Phila). 2016 Mar 29:1-5. [Epub ahead of print]
OBJECTIVE: Loperamide, a non-prescription anti-diarrheal agent, is a peripheral mu-opioid receptor agonist that is excluded from the blood-brain barrier by p-glycoprotein at therapeutic doses. Overdoses of loperamide penetrate the central nervous system (CNS), leading to abuse. We report cardiac conduction abnormalities and dysrhythmias after ingestion of a recreational supra-therapeutic dose of loperamide confirmed with an elevated blood loperamide concentration.
3.Proactive management strategies for potential gastrointestinal adverse reactions with ceritinib in patients with advanced ALK-positive non-small-cell lung cancer.
Schaefer ES1, Baik C2. Cancer Manag Res. 2016 Mar 24;8:33-8. doi: 10.2147/CMAR.S96471. eCollection 2016.
Anaplastic lymphoma kinase (ALK) gene fusions occur in 3%-7% of non-small-cell lung cancer (NSCLC) cases. Ceritinib, a once-daily, oral ALK inhibitor, has activity against crizotinib-resistant and crizotinib-naïve NSCLC, including brain metastases. Ceritinib (Zykadia™) was granted accelerated approval by the US Food and Drug Administration in 2014 for treating crizotinib-resistant ALK-positive NSCLC. Adverse events (AEs), particularly gastrointestinal (GI) AEs, are commonly experienced at the recommended dose of 750 mg/d and ∼38% of patients require dose interruption or reduction for GI AEs. This case study details our experience with the use of proactive GI AE management regimens in patients treated with ceritinib (750 mg/d) across two study sites. Proactive Regimens A and B were implemented in patients with metastatic ALK-positive NSCLC treated with ceritinib to manage drug-related GI AEs. Regimen A comprised ondansetron and diphenoxylate/atropine or loperamide, taken 30 minutes prior to ceritinib dose.
4.Evaluation of antidiarrheal activity of ethanolic extract of Holarrhena antidysenterica seeds in rats.
Sharma DK1, Gupta VK1, Kumar S1, Joshi V1, Mandal RS1, Prakash AG1, Singh M1. Vet World. 2015 Dec;8(12):1392-5. doi: 10.14202/vetworld.2015.1392-1395. Epub 2015 Dec 11.
AIM: The present study was conducted to evaluate the antidiarrheal effect of ethanolic extract of Holarrhena antidysenterica (Family - Apocynaceae) seeds against induced diarrhea in Wistar albino rats.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Opioid Receptor Products


GSK1521498
(CAS: 1007573-18-3)

GSK-1521498 is a novel μ-Opioid receptor antagonist. It shows to attenuate reward-driven compulsive behaviours, such as stimulant drug seeking or binge eating i...

CAS 1174130-61-0 LY-2456302

LY-2456302
(CAS: 1174130-61-0)

LY-2456302, also called as CERC-501, is a potent, highly selective and centrally-penetrant kappa opioid receptor antagonist(Ki= 0.807 nM)with favorable pharmaco...

CAS 59263-76-2 Meptazinol Hydrochloride

Meptazinol Hydrochloride
(CAS: 59263-76-2)

Meptazinol is a unique centrally active opioid analgesic, which inhibits [3H]-dihydromorphine binding with IC50 of 58 nM.

Enadoline hydrochloride
(CAS: 124439-07-2)

Enadolineis a potent selective Opioid kappa receptor agonists originated by Pfizer. However, clinical trials for the treatment of Arrhythmias, Neuroprotection a...

Naloxegol
(CAS: 854601-70-0)

Naloxegol is a CYP3A4 enzyme inhibitor. It is also a peripherally-selective opioid antagonist. It is used as the treatment of opioid-induced constipation. lt is...

CAS 16676-29-2 Naltrexone HCl

Naltrexone HCl
(CAS: 16676-29-2)

Naltrexone significantly suppresses ethanol self-administration and prevents ethanol-induced increases in dialysate dopamine levels.

Nalfurafine hydrochloride
(CAS: 152658-17-8)

Nalfurafine is a selective and centrally-penetrant κ-opioid receptor (KOR) agonist without significant activity on μ- and δ-opioid receptors. With antipruritic ...

BAN ORL 24
(CAS: 1401463-54-4)

BAN ORL 24, a spiro-isobenzofuran compound, has been found to be a NOP receptor antagonist and could be used to restrain the reduction of locomotor motions with...

CAS 1401031-39-7 TRV130 HCl

TRV130 HCl
(CAS: 1401031-39-7)

TRV130 is an opioid drug that is under evaluation in human clinical trials for the treatment of acute severe pain. It is a functionally selective μ-opioid recep...

LY-190388
(CAS: 105496-35-3)

LY-190388 is an μ receptor agonist. It is a penicillamine-containing enkephalin analog and has analgesia effect.

CAS 152657-84-6 Nalfurafine

Nalfurafine
(CAS: 152657-84-6)

Nalfurafine is a selective and centrally-penetrant κ-opioid receptor (KOR) agonist without significant activity on μ- and δ-opioid receptors. With antipruritic ...

PD-117302
(CAS: 111728-01-9)

PD-117302, a new nonpeptide opioid compound, is a selective kappa-opioid agonist. It has been evaluated in vivo for antinociceptive activity and other effects c...

CAS 152-02-3 Levallorphan

Levallorphan
(CAS: 152-02-3)

Levallorphan, an allylmorphinan derivative, has been found to be a μ-opioid receptor antagonist that could be an analgesic agent as an prescription drug.

CAS 141801-26-5 Endomorphin 2

Endomorphin 2
(CAS: 141801-26-5)

Endomorphin 2, an andogenous peptide, has high affinity and specificity for the μ-opioid receptor and displays reasonable affinities for kappa3 binding sites, w...

CAS 77614-16-5 Dermorphin

Dermorphin
(CAS: 77614-16-5)

Dermorphin, a naturally occurring heptapeptide originally found in the skin of amphibians, is a μ-opioid receptor(MOR) agonist with analgesic and antinociceptiv...

CAS 170098-38-1 Alvimopan dihydrate

Alvimopan dihydrate
(CAS: 170098-38-1)

Alvimopan dihydrate is a novel, orally available peripherally restricted opioid antagonist with low systemic absorption. It accelerates the gastrointestinal rec...

Odelepran
(CAS: 676501-25-0)

Odelepran is a opioid receptor antagonist. It is used for the treatment of alcohol dependence. It was developed by Lilly and was in clinical phase 2 trial, but ...

CAS 1354744-91-4 Naloxegol oxalate

Naloxegol oxalate
(CAS: 1354744-91-4)

Naloxegol oxalate is a CYP3A4 enzyme inhibitor, is a peripherally-selective opioid antagonist, for the treatment of opioid-induced constipation.

(+)-Igmesine hydrochloride
(CAS: 130152-35-1)

Igmesine is a selective σ1 receptor ligand (KD = 19.1 nM), with nearly no activity at σ2 receptors (IC50 > 1000 nM). It was developed by Pfizer. Igmesine inhibi...

CAS 58-74-2 Papaverine

Papaverine
(CAS: 58-74-2)

Papaverine is an opiate alkaloid isolated from the plant Papaver somniferum. It is used primarily in the treatment of visceral spasm, vasospasm. It is also used...

Chemical Structure

CAS 34552-83-5 Loperamide HCl

Quick Inquiry

Verification code

Featured Items